Model Number IMMULITE 2000 UE3 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
No Known Impact Or Consequence To Patient (2692)
|
Event Date 03/15/2017 |
Event Type
malfunction
|
Manufacturer Narrative
|
Siemens customer service engineer (cse) and field application specialist (fas) were dispatched to the customer site.Siemens cse and fas analyzed the instrument and did not find any instrument malfunction.The cause of the discordant, falsely low ue3 results on patient samples is unknown.The instrument is performing within manufacturing specifications.No further evaluation of device is required.
|
|
Event Description
|
The customer obtained discordant, falsely low unconjugated estriol (ue3) results on patient samples on an immulite 2000 xpi instrument.The discordant results were reported to the physician(s), who questioned them.It is unknown if the samples were repeated and if the repeat results were reported to the physician(s).There was delay in reporting of results.There are no known reports of patient intervention or adverse health consequences due to the discordant, falsely low ue3 results and delay in reporting of results.
|
|
Manufacturer Narrative
|
The initial mdr 2247117-2017-00053 was filed on april 28, 2017.Additional information (06/27/2017): a siemens technical operations specialist reviewed the performance of two lots of quality control materials across immulite 2000 xpi unconjugated estriol kit lots 297 through 311.There was no significant change in performance of the two lots of quality control materials for levels 1 (average dose of 0.55 ng/ml), 2 (average dose of 2.25 ng/ml) and 3 (average dose of 7.0 ng/ml) across the different kit lots of immulite 2000 xpi unconjugated estriol.All mean values were within +/- 1sd from the target mean.The allowable tolerance is +/- 2sd.Data review from a reference panel that contains 7 samples covering dose values from 0.38 ng/ml to 9.5 ng/ml across immulite 2000 xpi unconjugated estriol kit lots 297 through 311 did not indicate any significant changes in performance across the different kit lots.The available adjustment slopes for immulite 2000 xpi unconjugated estriol kit lots 296 through 311 were evaluated.Review of the data shows that kit lots 296 through 311 did not exceed an adjustment slope of 1.25.The instrument parameter for the upper limit of the adjustment slope is 1.8.A lower bias was observed on a few kit lots, however, this bias does not exceed the expectation of the assay.No product deficiency has been noted.The cause of the low unconjugated estriol results with kit lot 306 is unknown.The device is performing within manufacturing specifications.No further evaluation of the device is required.
|
|
Manufacturer Narrative
|
Additional information (09/14/2017): the kit lot affected was 309.
|
|
Search Alerts/Recalls
|